BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High-Neutropenia Risk Chemotherapy.

Pawloski, Pamala A; McDermott, Cara L; Marshall, James H; Pindolia, Vanita; Lockhart, Catherine M; Panozzo, Catherine A; Brown, Jeffrey S; Eichelberger, Bernadette

Pawloski, Pamala A; McDermott, Cara L; Marshall, James H; Pindolia, Vanita; Lockhart, Catherine M; Panozzo, Catherine A; Brown, Jeffrey S; Eichelberger, Bernadette.

Afiliação

Pawloski PA; 1HealthPartners Institute, Bloomington, Minnesota.
McDermott CL; 2Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, Virginia.
Marshall JH; 3Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; and.
Pindolia V; 4Henry Ford Health System, Detroit, Michigan.
Lockhart CM; 2Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, Virginia.
Panozzo CA; 3Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; and.
Brown JS; 3Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; and.
Eichelberger B; 2Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, Virginia.

J Natl Compr Canc Netw ; 2021 Aug 16.

Article em En | MEDLINE | ID: mdl-34399406

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Natl Compr Canc Netw Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google